NR546 MIDTERM EXAM - ADVANCED PHARMACOLOGY
PSYCHOPHARMACOLOGY FOR THE PSYCHIATRIC-
MENTAL HEALTH NURSE PRACTITIONER - ACTUAL
EXAM PRACTICE QUESTIONS AND 100% VERIFIED
CORRECT ANSWERS | COMPLETE EXAM PREP
TESTBANK | GUARANTEED PASS | INSTANT
DOWNLOAD PDF
Core Domains
1. Foundations of Psychopharmacology and Neurobiology
Neurotransmitters, receptor pharmacodynamics, pharmacokinetics,
pharmacogenomics, and CNS drug mechanisms.
2. Antidepressant Pharmacotherapy
SSRIs, SNRIs, TCAs, MAOIs, atypical antidepressants, treatment selection, side-effect
management.
3. Antipsychotic Pharmacology
First-generation and second-generation antipsychotics, receptor profiles, metabolic
effects, EPS management.
4. Mood Stabilizers and Bipolar Disorder Pharmacotherapy
Lithium, anticonvulsants, combination therapy, monitoring and toxicity management.
5. Anxiolytics, Sedative-Hypnotics, and Sleep Pharmacology
Benzodiazepines, non-benzodiazepine hypnotics, buspirone, melatonin agents.
6. ADHD and Cognitive Disorder Pharmacotherapy
Stimulants, non-stimulants, dosing considerations, abuse potential.
7. Psychopharmacology Across the Lifespan
Pediatric, geriatric, pregnancy and lactation considerations.
8. Adverse Effects, Drug Interactions, and Monitoring
Serotonin syndrome, metabolic syndrome, QT prolongation, CYP450 interactions.
9. Legal, Ethical, and Professional Standards in Psychiatric Prescribing
Controlled substance regulation, informed consent, prescribing authority,
documentation.
,Table of Contents
Section Topic Page
1 Introduction 1
2 Foundations of Psychopharmacology 2
3 Antidepressant Pharmacotherapy 4
4 Antipsychotic Pharmacology 6
5 Mood Stabilizers 8
6 Anxiolytics and Sedative-Hypnotics 10
7 ADHD and Cognitive Pharmacology 12
8 Psychopharmacology Across the Lifespan 14
9 Adverse Effects and Drug Interactions 16
10 Legal and Ethical Prescribing 18
11 Answer Key Summary 20
Introduction
The NR546 Advanced Psychopharmacology Midterm Examination evaluates the
psychiatric-mental health nurse practitioner student’s understanding of
pharmacologic principles used in psychiatric treatment. The exam assesses
knowledge of drug mechanisms, clinical indications, dosing strategies, adverse
effects, monitoring requirements, and regulatory considerations. Questions
emphasize clinical decision-making, requiring students to analyze patient scenarios
and select appropriate pharmacologic interventions. The assessment consists of
multiple-choice questions including recall-based, application-focused, and
scenario-based items. Successful candidates demonstrate competence in safe
prescribing practices, medication management, and evidence-based psychiatric
pharmacotherapy across diverse patient populations.
,SECTION I (Questions 1–35)
1. A psychiatric nurse practitioner explains that selective serotonin reuptake
inhibitors primarily increase synaptic serotonin by which mechanism?
A. Blocking presynaptic dopamine receptors
B. Increasing monoamine oxidase activity
C. Stimulating serotonin release from vesicles
D. Inhibiting serotonin reuptake transporters
Rationale: SSRIs block the serotonin transporter (SERT), preventing reuptake of
serotonin into presynaptic neurons and increasing serotonin availability in the
synaptic cleft.
2. Which neurotransmitter is most strongly associated with reward pathways and
motivation?
A. Serotonin
B. Dopamine
C. GABA
D. Acetylcholine
Rationale: Dopamine plays a central role in reward processing and reinforcement
pathways in the mesolimbic system.
3. A patient taking sertraline reports improvement after four weeks. Which
pharmacologic concept explains the delayed onset of antidepressant effect?
A. Rapid dopamine receptor downregulation
B. Immediate serotonin depletion
C. Adaptive receptor and intracellular signaling changes
D. Immediate norepinephrine receptor blockade
, Rationale: Antidepressant effects occur after downstream receptor adaptations
and neuroplastic changes rather than immediate neurotransmitter increases.
4. A psychiatric NP prescribes fluoxetine. Which pharmacokinetic property
distinguishes fluoxetine from many SSRIs?
A. Rapid metabolism with short half-life
B. Long half-life and active metabolite
C. Exclusive renal excretion
D. Lack of CYP450 interactions
Rationale: Fluoxetine has a long half-life and active metabolite (norfluoxetine),
which prolongs its pharmacologic activity.
5. A patient taking phenelzine develops severe hypertension after consuming aged
cheese. This reaction is caused by:
A. Serotonin toxicity
B. Dopamine receptor hypersensitivity
C. Tyramine accumulation due to MAO inhibition
D. Histamine receptor blockade
Rationale: MAOIs inhibit tyramine metabolism, leading to hypertensive crisis after
ingestion of tyramine-rich foods.
6. Which receptor blockade by antipsychotics is most associated with
extrapyramidal symptoms?
A. Serotonin 5-HT2A receptors
B. Histamine H1 receptors
PSYCHOPHARMACOLOGY FOR THE PSYCHIATRIC-
MENTAL HEALTH NURSE PRACTITIONER - ACTUAL
EXAM PRACTICE QUESTIONS AND 100% VERIFIED
CORRECT ANSWERS | COMPLETE EXAM PREP
TESTBANK | GUARANTEED PASS | INSTANT
DOWNLOAD PDF
Core Domains
1. Foundations of Psychopharmacology and Neurobiology
Neurotransmitters, receptor pharmacodynamics, pharmacokinetics,
pharmacogenomics, and CNS drug mechanisms.
2. Antidepressant Pharmacotherapy
SSRIs, SNRIs, TCAs, MAOIs, atypical antidepressants, treatment selection, side-effect
management.
3. Antipsychotic Pharmacology
First-generation and second-generation antipsychotics, receptor profiles, metabolic
effects, EPS management.
4. Mood Stabilizers and Bipolar Disorder Pharmacotherapy
Lithium, anticonvulsants, combination therapy, monitoring and toxicity management.
5. Anxiolytics, Sedative-Hypnotics, and Sleep Pharmacology
Benzodiazepines, non-benzodiazepine hypnotics, buspirone, melatonin agents.
6. ADHD and Cognitive Disorder Pharmacotherapy
Stimulants, non-stimulants, dosing considerations, abuse potential.
7. Psychopharmacology Across the Lifespan
Pediatric, geriatric, pregnancy and lactation considerations.
8. Adverse Effects, Drug Interactions, and Monitoring
Serotonin syndrome, metabolic syndrome, QT prolongation, CYP450 interactions.
9. Legal, Ethical, and Professional Standards in Psychiatric Prescribing
Controlled substance regulation, informed consent, prescribing authority,
documentation.
,Table of Contents
Section Topic Page
1 Introduction 1
2 Foundations of Psychopharmacology 2
3 Antidepressant Pharmacotherapy 4
4 Antipsychotic Pharmacology 6
5 Mood Stabilizers 8
6 Anxiolytics and Sedative-Hypnotics 10
7 ADHD and Cognitive Pharmacology 12
8 Psychopharmacology Across the Lifespan 14
9 Adverse Effects and Drug Interactions 16
10 Legal and Ethical Prescribing 18
11 Answer Key Summary 20
Introduction
The NR546 Advanced Psychopharmacology Midterm Examination evaluates the
psychiatric-mental health nurse practitioner student’s understanding of
pharmacologic principles used in psychiatric treatment. The exam assesses
knowledge of drug mechanisms, clinical indications, dosing strategies, adverse
effects, monitoring requirements, and regulatory considerations. Questions
emphasize clinical decision-making, requiring students to analyze patient scenarios
and select appropriate pharmacologic interventions. The assessment consists of
multiple-choice questions including recall-based, application-focused, and
scenario-based items. Successful candidates demonstrate competence in safe
prescribing practices, medication management, and evidence-based psychiatric
pharmacotherapy across diverse patient populations.
,SECTION I (Questions 1–35)
1. A psychiatric nurse practitioner explains that selective serotonin reuptake
inhibitors primarily increase synaptic serotonin by which mechanism?
A. Blocking presynaptic dopamine receptors
B. Increasing monoamine oxidase activity
C. Stimulating serotonin release from vesicles
D. Inhibiting serotonin reuptake transporters
Rationale: SSRIs block the serotonin transporter (SERT), preventing reuptake of
serotonin into presynaptic neurons and increasing serotonin availability in the
synaptic cleft.
2. Which neurotransmitter is most strongly associated with reward pathways and
motivation?
A. Serotonin
B. Dopamine
C. GABA
D. Acetylcholine
Rationale: Dopamine plays a central role in reward processing and reinforcement
pathways in the mesolimbic system.
3. A patient taking sertraline reports improvement after four weeks. Which
pharmacologic concept explains the delayed onset of antidepressant effect?
A. Rapid dopamine receptor downregulation
B. Immediate serotonin depletion
C. Adaptive receptor and intracellular signaling changes
D. Immediate norepinephrine receptor blockade
, Rationale: Antidepressant effects occur after downstream receptor adaptations
and neuroplastic changes rather than immediate neurotransmitter increases.
4. A psychiatric NP prescribes fluoxetine. Which pharmacokinetic property
distinguishes fluoxetine from many SSRIs?
A. Rapid metabolism with short half-life
B. Long half-life and active metabolite
C. Exclusive renal excretion
D. Lack of CYP450 interactions
Rationale: Fluoxetine has a long half-life and active metabolite (norfluoxetine),
which prolongs its pharmacologic activity.
5. A patient taking phenelzine develops severe hypertension after consuming aged
cheese. This reaction is caused by:
A. Serotonin toxicity
B. Dopamine receptor hypersensitivity
C. Tyramine accumulation due to MAO inhibition
D. Histamine receptor blockade
Rationale: MAOIs inhibit tyramine metabolism, leading to hypertensive crisis after
ingestion of tyramine-rich foods.
6. Which receptor blockade by antipsychotics is most associated with
extrapyramidal symptoms?
A. Serotonin 5-HT2A receptors
B. Histamine H1 receptors
